Author:
Sarper Türker Fevzi,Temiztürk Zeki,Azboy Davut
Abstract
For the previous years, the tricuspid valve (TV), has been studied relatively less than the other heart valves diseases both about pathophysiology, management, surgical intervention, and treatment. However, recent advances in assessment and management of the TV disease have led to redirect the interest in this “forgotten valve.” Surgeons often had believed that quick solutions for the left ventricle problems would also improve the secondary tricuspid regurgitation (STR). Every active surgeon has been preferred this quick solution in his whole surgery life many times. Medical treatment options aims to improve the underlying disease and the right ventricle failure. TV surgery have proven to yield good outcomes in surgery indicated patients. For patients who are not available for surgery, trans catheter intervention may be an alternative. Due to limited data, the best surgical techniques are still in question, with no clear answer, particularly for STR. Key factor in determining prognosis, timing for intervention and longer-term outcome is the right ventricular function at the time of prognosis.
Reference64 articles.
1. Arsalan M, Walther T, Smith RL, Grayburn PA. Tricuspid regurgitation diagnosis and treatment. European Heart Journal. 2017;38(9):634-638
2. Singh SK, Tang GH, Maganti MD, Armstrong S, Williams WG, David TE, et al. Midterm outcomes of tricuspid valve repair versus replacement for organic tricuspid disease. The Annals of Thoracic Surgery. 2006;82:1735-1741
3. Harris C, Croce B, Munkholm-Larsen S. Tricuspid valve disease. Annals of Cardiothoracic Surgery. 2017;6(3):294-294
4. El-Eshmawi A, Pandis D, Adams DH, Tang GH. Tricuspid valve surgery: Repair and replacement. Minerva Cardioangiologica. 2018;66(6):700-712
5. Haddad F, Hunt SA, Rosenthal DN, Murphy DJ. Right ventricular function in cardiovascular disease, part I. anatomy, physiology, aging, and functional assessment of the right ventricle. Circulation. 2008;117:1436-1448